| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antimetastatic, antineoplastic, and toxic effects of 4-hydroxycoumarin in a preclinical mouse melanoma model
|
Salinas-Jazmín, Nohemí
|
|
2009
|
65 |
5 |
p. 931-940
|
artikel
|
| 2 |
A phase IB dose-finding trial of liposomal doxorubicin in combination with capecitabine in patients with pretreated metastatic breast cancer
|
Rocca, Andrea
|
|
2009
|
65 |
5 |
p. 871-876
|
artikel
|
| 3 |
A phase I dose escalation study of a pharmacobiologically based scheduling of capecitabine and mitomycin C in patients with gastrointestinal malignancies
|
Bekaii-Saab, Tanios
|
|
2009
|
65 |
5 |
p. 863-869
|
artikel
|
| 4 |
A phase I/II trial of vorinostat in combination with 5-fluorouracil in patients with metastatic colorectal cancer who previously failed 5-FU-based chemotherapy
|
Wilson, Peter M.
|
|
2010
|
65 |
5 |
p. 979-988
|
artikel
|
| 5 |
A phase I trial of SJG-136 (NSC#694501) in advanced solid tumors
|
Janjigian, Yelena Y.
|
|
2009
|
65 |
5 |
p. 833-838
|
artikel
|
| 6 |
Artesunate induces oncosis-like cell death in vitro and has antitumor activity against pancreatic cancer xenografts in vivo
|
Du, Ji-Hui
|
|
2009
|
65 |
5 |
p. 895-902
|
artikel
|
| 7 |
Celecoxib inhibits MDR1 expression through COX-2-dependent mechanism in human hepatocellular carcinoma (HepG2) cell line
|
Roy, Karnati R.
|
|
2009
|
65 |
5 |
p. 903-911
|
artikel
|
| 8 |
Cetuximab-based therapy versus non-cetuximab therapy for advanced cancer: a meta-analysis of 17 randomized controlled trials
|
Liu, Lidan
|
|
2009
|
65 |
5 |
p. 849-861
|
artikel
|
| 9 |
Co-administration of irinotecan decreases the plasma concentration of an active metabolite of amrubicin, amrubicinol in rats
|
Maeda, Yukiko
|
|
2009
|
65 |
5 |
p. 953-959
|
artikel
|
| 10 |
DNA damage induced by the anthracycline cosmomycin D in DNA repair-deficient cells
|
Carvalho, Helotonio
|
|
2010
|
65 |
5 |
p. 989-994
|
artikel
|
| 11 |
Epidermal growth factor receptor (EGFR) mRNA levels and protein expression levels in primary colorectal cancer and corresponding liver metastases
|
Kuramochi, Hidekazu
|
|
2009
|
65 |
5 |
p. 825-831
|
artikel
|
| 12 |
Expression of an activated mammalian target of rapamycin (mTOR) in gastroenteropancreatic neuroendocrine tumors
|
Shida, Takashi
|
|
2009
|
65 |
5 |
p. 889-893
|
artikel
|
| 13 |
Extracellular fluid concentrations of cisplatin, carboplatin, and oxaliplatin in brain, muscle, and blood measured using microdialysis in nonhuman primates
|
Jacobs, Shana
|
|
2009
|
65 |
5 |
p. 817-824
|
artikel
|
| 14 |
Increased anti-tumour effects of doxorubicin and zoledronic acid in prostate cancer cells in vitro: supporting the benefits of combination therapy
|
Clyburn, Rhys D.
|
|
2009
|
65 |
5 |
p. 969-978
|
artikel
|
| 15 |
Induction of necrosis and cell cycle arrest in murine cancer cell lines by Melaleuca alternifolia (tea tree) oil and terpinen-4-ol
|
Greay, S. J.
|
|
2009
|
65 |
5 |
p. 877-888
|
artikel
|
| 16 |
In vitro assessment of cytochrome P450 inhibition and induction potential of azacitidine
|
Chen, Yong
|
|
2010
|
65 |
5 |
p. 995-1000
|
artikel
|
| 17 |
Limited inter-occasion variability in relation to inter-individual variability in chemotherapy-induced myelosuppression
|
Hansson, Emma K.
|
|
2009
|
65 |
5 |
p. 839-848
|
artikel
|
| 18 |
Mechanistic study of BNP7787-mediated cisplatin nephroprotection: modulation of gamma-glutamyl transpeptidase
|
Hausheer, Frederick H.
|
|
2009
|
65 |
5 |
p. 941-951
|
artikel
|
| 19 |
Optimization of the non-invasive 13C-sucrose breath test in a rat model of methotrexate-induced mucositis
|
Tooley, K. L.
|
|
2009
|
65 |
5 |
p. 913-921
|
artikel
|
| 20 |
Phase II study of motesanib in Japanese patients with advanced gastrointestinal stromal tumors with prior exposure to imatinib mesylate
|
Sawaki, Akira
|
|
2009
|
65 |
5 |
p. 961-967
|
artikel
|
| 21 |
Preclinical efficacy studies of a novel nanoparticle-based formulation of paclitaxel that out-performs Abraxane
|
Feng, Zhongling
|
|
2009
|
65 |
5 |
p. 923-930
|
artikel
|
| 22 |
Rapid and complete resolution of chemotherapy-induced thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS) with rituximab
|
Gourley, Brett L.
|
|
2010
|
65 |
5 |
p. 1001-1004
|
artikel
|
Tijdschrift beschrijving